
    
      Study design:The study is a prospective, single-center, single-arm, clinical study evaluating
      outcomes in pediatric subjects with intracranial dural arteriovenous fistulas treated with
      PHIL® device.

      Study purpose: To evaluate the safety and probable benefit of MicroVention, Inc. PHIL® Liquid
      Embolic material in the treatment of intracranial dural arteriovenous fistulas, alone or as
      an adjunctive treatment for dAVFs.
    
  